Clinical Scorecard: Role of Atopobiaceae Family in Modulating Immunometabolic Factors During Human Papillomavirus Infection and Cervical Cancer Development
At a Glance
Category
Detail
Condition
Human papillomavirus (HPV) infection and cervical cancer development
Key Mechanisms
Atopobiaceae modulate cervicovaginal microenvironment via inflammation, immune evasion, lipid and amino acid metabolism alterations
Target Population
Primarily Hispanic and non-Hispanic White premenopausal, nonpregnant women
Care Setting
Gynecologic and oncologic clinical settings involving HPV screening and cervical cancer diagnosis
Key Highlights
Atopobiaceae prevalence is higher in Hispanic women with increased gravidity and parity.
Atopobiaceae species (Fannyhessea vaginae, F. massiliense, F. species type 2) associate with high-risk HPV genotypes 31 and 52.
Atopobiaceae-rich profiles correlate positively with proinflammatory cytokines, immune checkpoint proteins, cancer biomarkers, and prooncogenic metabolites.
Guideline-Based Recommendations
Diagnosis
Utilize vaginal 16S rRNA sequencing to detect Atopobiaceae presence in cervicovaginal samples.
Perform HPV genotyping to identify high-risk HPV infections associated with Atopobiaceae colonization.
Management
Consider targeting Atopobiaceae to modulate the cervicovaginal microenvironment and potentially prevent HPV persistence and progression to cervical cancer.
Incorporate microbiome modulation strategies alongside HPV vaccination, especially in minority populations with emerging hrHPV types.
Monitoring & Follow-up
Monitor Atopobiaceae abundance as a biomarker for HPV persistence and cervical cancer risk.
Assess inflammatory cytokines, immune checkpoint proteins, and cancer biomarkers in patients with Atopobiaceae-rich microbiomes.
Risks
Atopobiaceae colonization may promote HPV persistence, immune evasion, and prooncogenic metabolic changes increasing cervical cancer risk.
Non-Lactobacillus dominant microbiomes, including Atopobiaceae, are linked to bacterial vaginosis and increased susceptibility to sexually transmitted infections.
Patient & Prescribing Data
Premenopausal, nonpregnant women stratified by HPV status and cervical lesion severity
Targeting Atopobiaceae may provide adjunctive benefit in preventing HPV persistence and cervical cancer progression, complementing existing HPV vaccination strategies.
Clinical Best Practices
Incorporate multiomics approaches (microbiome, immunoproteomics, metabolomics) for comprehensive assessment of cervicovaginal microenvironment.
Recognize racial/ethnic disparities in microbiome composition and HPV genotype prevalence when designing prevention and treatment strategies.
Use Atopobiaceae presence as a potential biomarker to identify women at higher risk for HPV persistence and cervical cancer development.
